Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Blood Bags Market Size, Share and Growth Outlook, 2026: Analysis By Product Configuration (Single Blood Bags, Double Blood Bags, Triple Blood Bags, Quadruple Blood Bags, Penta Blood Bags), By Material (PVC with DEHP , PVC DEHP-Free, Other Polymers ), By Application (Blood Collection, Blood Processing , Storage & Transportation), By End-User (Blood Banks, Hospitals & Clinics, Ambulatory Surgical Centers, Non-Governmental Organizations) Companies, and Country Forecast, 2021 to 2034

Global Blood Bags Market size is forecast to increase from $495.78 Million in 2026 to $699.67 Million in 2034 at a CAGR of 4.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005977
Pages: 228 Pages

Blood and Fluid Warming Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Intravenous In-Line Warming Systems, Surface, Enclosure), By Modality (Stationary Warming Devices, Portable), By Application (Surgery & Perioperative Care, Critical Care , Military & Pre-hospital EMS, Blood Banks & Apheresis Centers), By End-User (Hospitals, Ambulatory Surgical Centers , Diagnostic Centers) Companies, and Country Forecast, 2021 to 2034

Global Blood and Fluid Warming Devices Market size is forecast to increase from $1.95 Billion in 2026 to $3.8 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005976
Pages: 211 Pages

Blockchain Technology in Healthcare Market Size, Share and Growth Outlook, 2026: Analysis By Type (Public Blockchain, Private, Consortium), By Application (Clinical Data Exchange & Interoperability, Supply Chain Management , Clinical Trials & Consent Management, Claims Adjudication & Billing Management, Identity & Credential Management), By End-User (Pharmaceutical & Medical Device Companies, Healthcare Providers , Healthcare Payers , Patients & Health-Data Brokers) Companies, and Country Forecast, 2021 to 2034

Global Blockchain Technology in Healthcare Market size is forecast to increase from $12.43 Billion in 2026 to $245.59 Billion in 2034 at a CAGR of 45.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005975
Pages: 219 Pages

Blockbuster Oncology Brands Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (PD-1, HER2, CDK4, BTK Inhibitors, PARP Inhibitors, Monoclonal Antibodies , CAR-T Cell Therapies), By Primary Indication (Breast Cancer Brands, Lung Cancer Brands , Hematologic Malignancy Brands , Prostate Cancer Brands, Colorectal Cancer Brands, Melanoma & Immuno-Oncology Brands), By Therapy Modality (Monotherapy Brands, Combination Regimen Brands), By Distribution & Access (Specialty Pharmacies, In-patient, Government) Companies, and Country Forecast, 2021 to 2034

Global Blockbuster Oncology Brands Market size is forecast to increase from $53.46 Million in 2026 to $98.22 Million in 2034 at a CAGR of 7.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005974
Pages: 230 Pages

Blepharitis Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Antibiotics , Steroids, Anti-inflammatory Agents , Lubricating Eye Drops , Ectoparasiticides ), By Application (Anterior Blepharitis Treatment, Posterior Blepharitis Treatment ), By Dosage Form (Ophthalmic Solutions, Eye Ointments & Gels, Oral Tablets, Eyelid Cleansers & Scrubs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Blepharitis Drugs Market size is forecast to increase from $1.68 Billion in 2026 to $2.52 Billion in 2034 at a CAGR of 5.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005973
Pages: 210 Pages

Bleeding Disorders Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Non-factor Replacement Therapies, Antifibrinolytic Drugs, Desmopressin, Gene Therapy), By Disease Indication (Hemophilia A, Hemophilia B, Von Willebrand Disease , Rare Factor Deficiencies , Acquired Bleeding Disorders), By Treatment Modality (Prophylaxis Treatment, On-demand), By End-User (Hospitals & Clinics, Hemophilia Treatment Centers , Home Healthcare) Companies, and Country Forecast, 2021 to 2034

Global Bleeding Disorders Treatment Market size is forecast to increase from $21.89 Billion in 2026 to $37.33 Billion in 2034 at a CAGR of 6.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005972
Pages: 220 Pages

Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Setting (First-line Therapy, Relapsed or Refractory Therapy), By Therapeutic Modality (Targeted Therapy, Chemotherapy Regimens , Immunotherapy and Stem Cell Transplantation , Emerging Pipeline Therapies), By Patient Eligibility (Transplant-Eligible Patients , Transplant-Ineligible Patients ), By End-User (Hospitals and Specialized Cancer Centers, Bone Marrow Transplant Centers, Academic and Clinical Research Institutes), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market size is forecast to increase from $186.44 Million in 2026 to $325.16 Million in 2034 at a CAGR of 7.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005971
Pages: 218 Pages

Bladder Scanner Market Size, Share and Growth Outlook, 2026: Analysis By Product (2D Ultrasound Bladder Scanners, 3D Ultrasound Bladder Scanners), By Portability (Portable , Handheld Scanners, Bench-top Scanners), By Imaging Technology (Conventional Imaging Systems, AI-Enabled ), By Clinical Application (Urology, Obstetrics & Gynecology, Emergency Medicine, Peri-operative , Rehabilitation & Physiotherapy), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers , Diagnostic Imaging Centers, Long-Term Care Facilities & Nursing Homes, Home Healthcare Settings) Companies, and Country Forecast, 2021 to 2034

Global Bladder Scanner Market size is forecast to increase from $249.99 Million in 2026 to $407.56 Million in 2034 at a CAGR of 6.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005970
Pages: 210 Pages

Bladder Cancer Therapeutics and Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Product Category (Therapeutics, Diagnostics), By Therapeutic Modality (Immunotherapy, Chemotherapy, Antibody-Drug Conjugates , Targeted Therapy, Radiation Therapy), By Diagnostic Test (Cystoscopy, Bladder Ultrasound and Imaging, Urinalysis and Urine Cytology, Liquid Biopsy and Biomarker Panels), By Cancer Type (Urothelial , Squamous-Cell Carcinoma, Adenocarcinoma), By Disease Stage (Non-Muscle-Invasive Bladder Cancer , Muscle-Invasive Bladder Cancer ), By End-User (Hospitals and Oncology Centers, Ambulatory Surgical Centers , Diagnostic and Pathology Laboratories, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Bladder Cancer Therapeutics and Diagnostics Market size is forecast to increase from $473.34 Million in 2026 to $863.22 Million in 2034 at a CAGR of 7.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005969
Pages: 227 Pages

Bispecific Antibody Therapeutics Contract Manufacturing Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Process Development, Fill-Finish, Analytical Testing, GMP Manufacturing), By Production Scale (Clinical Scale, Commercial Scale), By Expression System (Mammalian, Microbial, Other Systems), By End-User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutes) Companies, and Country Forecast, 2021 to 2034

Global Bispecific Antibody Therapeutics Contract Manufacturing Market size is forecast to increase from $8.61 Billion in 2026 to $65.62 Billion in 2034 at a CAGR of 28.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005968
Pages: 221 Pages